2002
DOI: 10.1016/s0360-3016(02)03036-5
|View full text |Cite
|
Sign up to set email alerts
|

Using the magnitude of PSA bounce after MRI-guided prostate brachytherapy to distinguish recurrence, benign precipitating factors, and idiopathic bounce

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
36
0

Year Published

2007
2007
2014
2014

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 60 publications
(39 citation statements)
references
References 13 publications
1
36
0
Order By: Relevance
“…Prior studies used different isotopes and administered EBRT with or without brachytherapy. 4,5,8,9,18,19 PSA bounce is a common phenomenon after brachytherapy. PSA bounce has previously been defi ned as an increase of more than 0.1 ng/ml, 3,5,8,9,12 followed by a subsequent decrease to less than that level; as an increase of more than 0.2 ng/ml, 2,3,6,7,11 followed by a decline or a minimal rise of 0.4 ng/ml 3,5,12 during a 3-6 month period, followed by a drop of any magnitude; or as a more than 35% elevation 5,12 in PSA compared with the most recent value, followed by a decline to a level at or less than the prebounce value.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Prior studies used different isotopes and administered EBRT with or without brachytherapy. 4,5,8,9,18,19 PSA bounce is a common phenomenon after brachytherapy. PSA bounce has previously been defi ned as an increase of more than 0.1 ng/ml, 3,5,8,9,12 followed by a subsequent decrease to less than that level; as an increase of more than 0.2 ng/ml, 2,3,6,7,11 followed by a decline or a minimal rise of 0.4 ng/ml 3,5,12 during a 3-6 month period, followed by a drop of any magnitude; or as a more than 35% elevation 5,12 in PSA compared with the most recent value, followed by a decline to a level at or less than the prebounce value.…”
Section: Discussionmentioning
confidence: 99%
“…2 Approximately 15%-60% of hormone-naive patients show a temporary PSA elevation after brachytherapy. [2][3][4][5][6][7][8][9][10][11][12] It has been proposed that this PSA "bounce" is probably the result of some mechanism compromising membrane integrity; that is, radiation-induced prostatitis, in PSA-producing epithelium. In 1997, the American Society for Therapeutic Radiology and Oncology (ASTRO) consensus conference recommended three consecutive increases in PSA levels after the nadir, with readings spaced 3-6 months apart, as the defi nition of biochemical failure.…”
Section: Introductionmentioning
confidence: 99%
“…An alternative management approach is to recommend no antibiotics for patients with an increasing PSA bounce and to simply follow their PSAs [24]. Known precipitating factors of a PSA bounce are recent ejaculation, proctitis, or instrumentation [25]. In the absence of these factors, a PSA bounce is referred to as being idiopathic [25].…”
Section: Discussionmentioning
confidence: 99%
“…Known precipitating factors of a PSA bounce are recent ejaculation, proctitis, or instrumentation [25]. In the absence of these factors, a PSA bounce is referred to as being idiopathic [25].…”
Section: Discussionmentioning
confidence: 99%
“…Subsequent reports from the same team indicated that MRI-guided brachytherapy is a safe alternative to USguided brachytherapy (35)(36)(37)(38)(39).…”
Section: Mr-guided Prostate Cancer Brachytherapymentioning
confidence: 99%